FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

27567611000001107: Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Nov 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
87511501000001110 Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
87511601000001114 Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

7 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Has VMP Umeclidinium bromide 65micrograms/dose dry powder inhaler true Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Has specific active ingredient Umeclidinium bromide false Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Has specific active ingredient Umeclidinium bromide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Incruse Ellipta 55micrograms/dose dry powder inhaler (Ethigen Ltd) 30 dose Is a True Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Pharmaram Ltd) 30 dose Is a True Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (DE Pharmaceuticals) 30 dose Is a True Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (CST Pharma Ltd) 30 dose Is a True Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Is a True Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Inferred relationship Existential restriction modifier
Rolufta Ellipta 55micrograms/dose dry powder inhaler (Ethigen Ltd) 30 dose Is a True Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose Is a True Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start